Alpha Teknova Inc (TKNO) ニュース

Form 8-K - Current report

Teknova Reports Fourth Quarter and Full Year 2024 Financial Results

Full year 2024 total revenue was $37.7 million, up 3% year-over-year and in line with guidanceFourth quarter...

Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Teknova Reports Third Quarter 2024 Financial Results

Third quarter 2024 total revenue was $9.6 million, up 17% over the same quarter prior yearCompany lowers 2024...

Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024

HOLLISTER, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Teknova Reports Second Quarter 2024 Financial Results

Second quarter 2024 total revenue was $9.6 million, up 3% sequentiallyRaised $15.4 million of equity capital in...

Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development

Express-TekSM Production enables customers to have their products enter production in days instead of weeks...

Teknova to Report Second Quarter 2024 Financial Results on August 13, 2024

HOLLISTER, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a...

Form D - Notice of Exempt Offering of Securities